This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Armas, L. A. G. Articles by Heaney, R. P. Search for Related Content PubMed PubMed Citation Articles by Armas, L. A. G. Articles by Heaney, R. P.

Vitamin D₂ Is Much Less Effective than Vitamin D₃ in Humans

Creighton University (L.A.G.A., R.P.H.), Omaha, Nebraska 68131; and Medical University of South Carolina (B.W.H.), Charleston, South Carolina 29425

Address all correspondence and requests for reprints to: Robert P. Heaney, M.D., Creighton University, 601 North 30th Street, Suite 4841, Omaha, Nebraska 68131. E-mail: rheaney{at}creighton.edu.

Vitamins D₂ and D₃ are generally considered to be equivalent in humans. Nevertheless, physicians commonly report equivocal responses to seemingly large doses of the only high-dose calciferol (vitamin D₂) available in the U.S. market.

The relative potencies of vitamins D₂ and D₃ were evaluated by administering single doses of 50,000 IU of the respective calciferols to 20 healthy male volunteers, following the time course of serum vitamin D and 25-hydroxyvitamin D (25OHD) over a period of 28 d and measuring the area under the curve of the rise in 25OHD above baseline.

The two calciferols produced similar rises in serum concentration of the administered vitamin, indicating equivalent absorption. Both produced similar initial rises in serum 25OHD over the first 3 d, but 25OHD continued to rise in the D₃-treated subjects, peaking at 14 d, whereas serum 25OHD fell rapidly in the D₂-treated subjects and was not different from baseline at 14 d. Area under the curve (AUC) to d 28 was 60.2 ng·d/ml (150.5 nmol·d/liter) for vitamin D₂ and 204.7 (511.8) for vitamin D₃ (P < 0.002). Calculated AUC indicated an even greater differential, with the relative potencies for D₃:D₂ being 9.5:1.

Vitamin D₂ potency is less than one third that of vitamin D₃. Physicians resorting to use of vitamin D₂ should be aware of its markedly lower potency and shorter duration of action relative to vitamin D₃.

This article has been cited by other articles:

				R. Scragg and C. A. Camargo Jr. Frequency of Leisure-Time Physical Activity and Serum 25-Hydroxyvitamin D Levels in the US Population: Results from the Third National Health and Nutrition Examination Survey Am. J. Epidemiol., September 15, 2008; 168(6): 577 - 586. [Abstract] [Full Text] [PDF]

				R. P. Heaney Vitamin D in Health and Disease Clin. J. Am. Soc. Nephrol., September 1, 2008; 3(5): 1535 - 1541. [Abstract] [Full Text] [PDF]

				P. Leventis and S. Patel Clinical aspects of vitamin D in the management of rheumatoid arthritis Rheumatology, August 5, 2008; (2008) ken296v1. [Abstract] [Full Text] [PDF]

				A. W Norman From vitamin D to hormone D: fundamentals of the vitamin D endocrine system essential for good health Am. J. Clinical Nutrition, August 1, 2008; 88(2): 491S - 499S. [Abstract] [Full Text] [PDF]

				B. W Hollis Measuring 25-hydroxyvitamin D in a clinical environment: challenges and needs Am. J. Clinical Nutrition, August 1, 2008; 88(2): 507S - 510S. [Abstract] [Full Text] [PDF]

				A. Cranney, H. A Weiler, S. O'Donnell, and L. Puil Summary of evidence-based review on vitamin D efficacy and safety in relation to bone health Am. J. Clinical Nutrition, August 1, 2008; 88(2): 513S - 519S. [Abstract] [Full Text] [PDF]

				E. Romagnoli, M. L. Mascia, C. Cipriani, V. Fassino, F. Mazzei, E. D'Erasmo, V. Carnevale, A. Scillitani, and S. Minisola Short and Long-Term Variations in Serum Calciotropic Hormones after a Single Very Large Dose of Ergocalciferol (Vitamin D2) or Cholecalciferol (Vitamin D3) in the Elderly J. Clin. Endocrinol. Metab., August 1, 2008; 93(8): 3015 - 3020. [Abstract] [Full Text] [PDF]

				M. Misra, D. Pacaud, A. Petryk, P. F. Collett-Solberg, M. Kappy, and on behalf of the Drug and Therapeutics Committee o Vitamin D Deficiency in Children and Its Management: Review of Current Knowledge and Recommendations Pediatrics, August 1, 2008; 122(2): 398 - 417. [Abstract] [Full Text] [PDF]

				F. Tokmak, I. Quack, G. Schieren, L. Sellin, D. Rattensperger, T. Holland-Letz, S. M. Weiner, and L. C. Rump High-dose cholecalciferol to correct vitamin D deficiency in haemodialysis patients Nephrol. Dial. Transplant., July 1, 2008; (2008) gfn367v1. [Abstract] [Full Text] [PDF]

				J. Maalouf, M. Nabulsi, R. Vieth, S. Kimball, R. El-Rassi, Z. Mahfoud, and G. El-Hajj Fuleihan Short- and Long-Term Safety of Weekly High-Dose Vitamin D3 Supplementation in School Children J. Clin. Endocrinol. Metab., July 1, 2008; 93(7): 2693 - 2701. [Abstract] [Full Text] [PDF]

				I. Cantor Shedding Light on Vitamin D and Integrative Oncology Integr Cancer Ther, June 1, 2008; 7(2): 81 - 89. [Abstract] [PDF]

				L. Gehrig, J. Lane, and M. I. O'Connor Osteoporosis: Management and Treatment Strategies for Orthopaedic Surgeons J. Bone Joint Surg. Am., June 1, 2008; 90(6): 1362 - 1374. [Full Text] [PDF]

				N. Binkley, D. Krueger, D. Gemar, and M. K. Drezner Correlation among 25-Hydroxy-Vitamin D Assays J. Clin. Endocrinol. Metab., May 1, 2008; 93(5): 1804 - 1808. [Abstract] [Full Text] [PDF]

				M. F Holick and T. C Chen Vitamin D deficiency: a worldwide problem with health consequences Am. J. Clinical Nutrition, April 1, 2008; 87(4): 1080S - 1086S. [Abstract] [Full Text] [PDF]

				J. E Zerwekh Blood biomarkers of vitamin D status Am. J. Clinical Nutrition, April 1, 2008; 87(4): 1087S - 1091S. [Abstract] [Full Text] [PDF]

				M. Ilahi, L. A. Armas, and R. P Heaney Pharmacokinetics of a single, large dose of cholecalciferol Am. J. Clinical Nutrition, March 1, 2008; 87(3): 688 - 691. [Abstract] [Full Text] [PDF]

				H. J. Roth, H. Schmidt-Gayk, H. Weber, and C. Niederau Accuracy and clinical implications of seven 25-hydroxyvitamin D methods compared with liquid chromatography-tandem mass spectrometry as a reference Ann Clin Biochem, March 1, 2008; 45(2): 153 - 159. [Abstract] [Full Text] [PDF]

				K. Zhu, A. Devine, I. M. Dick, S. G. Wilson, and R. L. Prince Effects of Calcium and Vitamin D Supplementation on Hip Bone Mineral Density and Calcium-Related Analytes in Elderly Ambulatory Australian Women: A Five-Year Randomized Controlled Trial J. Clin. Endocrinol. Metab., March 1, 2008; 93(3): 743 - 749. [Abstract] [Full Text] [PDF]

				M. F. Holick, R. M. Biancuzzo, T. C. Chen, E. K. Klein, A. Young, D. Bibuld, R. Reitz, W. Salameh, A. Ameri, and A. D. Tannenbaum Vitamin D2 Is as Effective as Vitamin D3 in Maintaining Circulating Concentrations of 25-Hydroxyvitamin D J. Clin. Endocrinol. Metab., March 1, 2008; 93(3): 677 - 681. [Abstract] [Full Text] [PDF]

				R. L. Prince, N. Austin, A. Devine, I. M. Dick, D. Bruce, and K. Zhu Effects of Ergocalciferol Added to Calcium on the Risk of Falls in Elderly High-Risk Women Arch Intern Med, January 14, 2008; 168(1): 103 - 108. [Abstract] [Full Text] [PDF]

				A. Stephenson Reply to E Robberecht and S Vandewalle Am. J. Clinical Nutrition, January 1, 2008; 87(1): 190 - 191. [Full Text] [PDF]

				H. Smith, F. Anderson, H. Raphael, P. Maslin, S. Crozier, and C. Cooper Effect of annual intramuscular vitamin D on fracture risk in elderly men and women a population-based, randomized, double-blind, placebo-controlled trial Rheumatology, December 1, 2007; 46(12): 1852 - 1857. [Abstract] [Full Text] [PDF]

				M. F. Holick Vitamin D Deficiency N. Engl. J. Med., July 19, 2007; 357(3): 266 - 281. [Full Text] [PDF]

				H. F Saadi, A. Dawodu, B. O Afandi, R. Zayed, S. Benedict, and N. Nagelkerke Efficacy of daily and monthly high-dose calciferol in vitamin D-deficient nulliparous and lactating women Am. J. Clinical Nutrition, June 1, 2007; 85(6): 1565 - 1571. [Abstract] [Full Text] [PDF]

				M. Yano, M. Ikeda, K.-i. Abe, H. Dansako, S. Ohkoshi, Y. Aoyagi, and N. Kato Comprehensive Analysis of the Effects of Ordinary Nutrients on Hepatitis C Virus RNA Replication in Cell Culture Antimicrob. Agents Chemother., June 1, 2007; 51(6): 2016 - 2027. [Abstract] [Full Text] [PDF]

				A. Stephenson, M. Brotherwood, R. Robert, E. Atenafu, M. Corey, and E. Tullis Cholecalciferol significantly increases 25-hydroxyvitamin D concentrations in adults with cystic fibrosis Am. J. Clinical Nutrition, May 1, 2007; 85(5): 1307 - 1311. [Abstract] [Full Text] [PDF]

				J. N Hathcock, A. Shao, R. Vieth, and R. Heaney Risk assessment for vitamin D Am. J. Clinical Nutrition, January 1, 2007; 85(1): 6 - 18. [Abstract] [Full Text] [PDF]

				W. B. Grant Cholecalciferol, not ergocalciferol, should be used for vitamin D supplementation Age Ageing, November 1, 2006; 35(6): 645 - 645. [Full Text] [PDF]

				L. A Houghton and R. Vieth The case against ergocalciferol (vitamin D2) as a vitamin supplement. Am. J. Clinical Nutrition, October 1, 2006; 84(4): 694 - 697. [Abstract] [Full Text] [PDF]

				H. S. Lam, C. M. Chow, W. T. Poon, C. K. Lai, K. C. A. Chan, W. L. Yeung, J. Hui, A. Y. W. Chan, and P. C. Ng Risk of Vitamin A Toxicity From Candy-Like Chewable Vitamin Supplements for Children Pediatrics, August 1, 2006; 118(2): 820 - 824. [Abstract] [Full Text] [PDF]

				G. L. Lensmeyer, D. A. Wiebe, N. Binkley, and M. K. Drezner HPLC Method for 25-Hydroxyvitamin D Measurement: Comparison with Contemporary Assays Clin. Chem., June 1, 2006; 52(6): 1120 - 1126. [Abstract] [Full Text] [PDF]

				E. Giovannucci, Y. Liu, E. B. Rimm, B. W. Hollis, C. S. Fuchs, M. J. Stampfer, and W. C. Willett Prospective study of predictors of vitamin d status and cancer incidence and mortality in men. J Natl Cancer Inst, April 5, 2006; 98(7): 451 - 459. [Abstract] [Full Text] [PDF]

				R. Vieth Critique of the Considerations for Establishing the Tolerable Upper Intake Level for Vitamin D: Critical Need for Revision Upwards J. Nutr., April 1, 2006; 136(4): 1117 - 1122. [Abstract] [Full Text] [PDF]

				T. J. Allain Vitamin D and fracture prevention--treatment still indicated but clarification needed Age Ageing, November 1, 2005; 34(6): 542 - 544. [Full Text] [PDF]

				J. L. Johnson, V. V. Mistry, M. D. Vukovich, T. Hogie-Lorenzen, B. W. Hollis, and B. L. Specker Bioavailability of Vitamin D from Fortified Process Cheese and Effects on Vitamin D Status in the Elderly J Dairy Sci, July 1, 2005; 88(7): 2295 - 2301. [Abstract] [Full Text] [PDF]

				K. Ramakrishnan and M. F. Holick Underestimation of Serum 25-Hydroxyvitamin D by the Nichols Advantage Assay in Patients Receiving Vitamin D Replacement Therapy - Reply Clin. Chem., June 1, 2005; 51(6): 1074 - 1074. [Full Text] [PDF]

				G. T.Y. Chung, R. W.K. Chiu, K.C. A. Chan, T. K. Lau, T. N. Leung, L. W. Chan, and Y.M. D. Lo Detrimental Effect of Formaldehyde on Plasma RNA Detection Clin. Chem., June 1, 2005; 51(6): 1074 - 1076. [Full Text] [PDF]

				H. A. Bischoff-Ferrari, W. C. Willett, J. B. Wong, E. Giovannucci, T. Dietrich, and B. Dawson-Hughes Fracture Prevention With Vitamin D Supplementation: A Meta-analysis of Randomized Controlled Trials JAMA, May 11, 2005; 293(18): 2257 - 2264. [Abstract] [Full Text] [PDF]

				B. Dawson-Hughes The Role of Vitamin D in Fracture Prevention IBMS BoneKEy, April 1, 2005; 2(4): 6 - 10. [Full Text] [PDF]

				E. Seeman and G. J. Strewler Clinical and Basic Research Papers - November 2004 Selections IBMS BoneKEy, December 1, 2004; 1(12): 1 - 2. [Full Text] [PDF]